A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

Status:
NOT_YET_RECRUITING

Trial end date:
2028-08-18

Target enrollment:

Participant gender:

Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163.

PHASE2

AstraZeneca